4//SEC Filing
Moukheibir Catherine 4
Accession 0001213900-24-050835
CIK 0001821586other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:01 PM ET
Size
5.9 KB
Accession
0001213900-24-050835
Insider Transaction Report
Form 4
Moukheibir Catherine
Director
Transactions
- Award
Option to Buy
2024-06-06+7,688→ 7,688 totalExercise: $42.44Exp: 2034-06-06→ Class A ordinary shares, par value $0.0001 per share (7,688 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 7,688 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 6, 2025, (ii) the date of the Issuer's next annual general meeting of shareholders and (iii) the date of a Change in Control (as defined in the MoonLake Immunotherapeutics 2022 Equity Incentive Plan) of the Issuer, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001772130
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 5:01 PM ET
- Size
- 5.9 KB